Carotid artery stenting (CAS) has a fatal complication of intracranial hemorrhage (ICH) associated with cerebral hyperperfusion syndrome (CHS), i.e. brain hemorrhage and subarachnoid hemorrhage (SAH). Although SAH accounts for a small percentage of these patients, it is difficult to make a differential diagnosis of this syndrome from CHS without ICH because the clinical presentations resemble each other. Furthermore, not only does the cause of SAH following CAS remain unclear but also the role of controlling postoperative blood pressure is not detected in preventing ICH after CAS. Herein, we report a case of SAH following CAS and review previous literature to discuss the mechanism and the management of this fatal complication. A 78-year-old woman with a history of arteriosclerotic obliteration and myocardial infarction was referred to our department for intervention to asymptomatic severe stenosis of the right internal carotid artery. We performed CAS under local anesthesia. Although her blood pressure was controlled to normotension during the procedure, the patient complained of headache following predilation. Postoperative emergent non-contrast computed tomography revealed SAH with leakage of contrast medium occupying the right sylvian fissure. We continued strict blood pressure control, and the patient was discharged without any neurological deficit. A well-opened lumen of the stent was recognized three months later at the outpatient visit. Strict control of intraoperative and postoperative blood pressure may improve the outcome of SAH following CAS though the role in preventing ICH after CAS is unclear.
Introduction
Carotid artery stenting (CAS) has been widely performed as an alternative to carotid endarterectomy (CEA) for carotid artery stenosis, and is rather preferred especially for patients with a history of coronary disease. 1, 2 Hemodynamic instability after CAS consists of hypertension, hypotension, bradycardia, and cerebral hyperperfusion syndrome (CHS). Of these complications, intracranial hemorrhage (ICH) associated with CHS has a fatal outcome though incidence is rare at 0.63 0.72%. 3, 4 ICH after CAS is classified into brain hemorrhage and subarachnoid hemorrhage (SAH). While brain hemorrhage accounts for more than 80% of ICH after CAS associated with CHS, SAH accounts for a small percentage of these patients. 4, 5 It is difficult to make a differential diagnosis of SAH following CAS from CHS without ICH because SAH presents with severe headache, nausea, and vomiting but usually lacks hemiplegia, whose symptoms resemble that of CHS without ICH. Furthermore, not only the mechanism but also the management of SAH following CAS remains unclear. 5, 6 Although strict control of postoperative blood pressure is proved to prevent postoperative ICH in cases of CEA, the role of strict blood pressure control is controversial in cases of CAS. 4 To our best knowledge, only seven cases of SAH following CAS have been reported and the mortality rate reaches 70%. [5] [6] [7] [8] [9] [10] Accumulating experience about this rare syndrome will improve the understanding and the poor outcome. We report a case of SAH following CAS with good clinical outcome and review previous literature to discuss the mechanism and the management of this fatal complication.
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A 78-year-old woman with a history of arteriosclerotic obliteration and myocardial infarction was referred to our department for intervention of asymptomatic severe stenosis of the right internal carotid artery. Cervical echo revealed 85% stenosis of North American Symptomatic Carotid Endarterectomy Trial (NASCET) with iso-echoic plaque. Computed tomography (CT) showed calcification of the anterior wall. Magnetic resonance imaging of black-blood showed high intensity of the plaque. Acetazolamideenhanced N-isopropyl-p-iodoamphetamine singlephoton emission computed tomography (SPECT) showed poor vascular reactivity of the right hemisphere ( Figure 1 (a), (b)). 11 We performed CAS under local anesthesia.
The patient had received dual antiplatelet therapy (aspirin 100 mg/day and cilostazol 200 mg/day) for arteriosclerotic obliteration and myocardial infarction. The procedure was performed under local anesthesia via a femoral artery route with a 9-F sheath (Medikit, Tokyo, Japan). A bolus infusion of 5000 IU heparin and continuous intravenous infusion of 1000 IU/h heparin were given to control activated clotting time from 250 to 300 seconds. A 9-F guiding catheter Optimo (Tokai Medical Products, Aichi, Japan) was placed into the right common carotid artery via the co-axial method using a 6-F catheter CATHEX JB2 (Gadelius Medical, Tokyo, Japan). Diagnostic study was performed and severe stenosis of the right internal carotid artery with delayed blood flow was confirmed (Figure 2 (a)).
PercuSurge GuardWire (Medtronic, Minneapolis, MN, USA) was placed into the external carotid artery. Then, PercuSurge and Optimo balloons were inflated and 0.014-inch Transend EX Guidewire (Boston Scientific, Natick, MA, USA) crossed the lesion. Predilation was performed with a SHIDEN PTA balloon 2.0 * 40 mm (Kaneka Medical Products, Osaka, Japan) and subsequently with a Starling PTA balloon 3.5 mm * 40 mm (Boston Scientific, Natick, MA, USA). Blood flow improved substantially ( Figure 2(b) ). Immediately after the dilation procedure, the patient complained of headache though wire perforation was not detected. We continued the procedure because she remained alert and no focal neurological deficit was detected. Her blood pressure maintained normotension during the procedure from 100/70 to 120/80 mmHg.
We attempted to insert a Protege RX 7-10 mm * 40 mm (ev3 Neurovascular, Irvine, CA, USA) but it did not cross the lesion. Accordingly, the lesion was dilated again by an Aviator Plus PTA balloon 5 * 40 mm (Cordis, Fremont, CA, USA) and a stent was placed into the lesion. Because the following angiography revealed distally shifted stent (Figure 2 (c)), we planned to add another stent. We tried to insert a SMART STENT 10 * 10 mm (Cordis, Fremont, CA, USA) but it did not cross the lesion. The lesion was dilated by a Starling PTA balloon 3.5 * 40 mm and subsequently by an Aviator Plus PTA balloon 5 * 40 mm. Then, the second stent was placed appropriately. Twice postdilation for the two stents was performed by Starling PTA balloons 5.0 * 20 mm each for 30 seconds. Angiography confirmed the internal carotid artery stenosis improved to 40% without dissection or thrombosis (Figure 2(d) ).
Immediately after the procedure, the patient complained of headache and vomited. We performed emergency non-contrast CT (NCCT) and detected SAH with leakage of contrast medium occupying the right sylvian fissure (Figure 3 (a), (b)). A second NCCT that was performed three hours later showed increased SAH extending to the basal cistern ( Figure 3 (c), (d)). A third NCCT six hours later after the CAS showed decreased SAH, which suggested the bleeding had stopped. Through the postoperative course described above, we continued strict blood pressure control but did not reverse the anticoagulant effect because the patient remained alert and the SAH was not massive. Five days after the procedure, non-enhanced N-isopropyl-p-iodoamphetamine SPECT showed that the CHS had extinguished on the right hemisphere (Figure 1(c) ), and the patient was discharged without any neurological deficit. Cervical echo study showed a well-opened lumen of the stent three months later at the outpatient visit.
Discussion
The incidence of CHP following CAS ranges from 1.1% to 5.0%. 4, 12 CHP is characterized by the symptoms of ipsilateral headaches, nausea, vomiting, focal seizures, and altered mental status usually associated with elevated blood pressure. 7, 13 Although the incidence of SAH following CAS associated with CHP occurs only in 0.07% of patients after CAS, 4 the syndrome has a fatal outcome of 70% mortality. On the other hand, it is difficult to make a differential diagnosis of SAH following CAS without imaging studies from CHS without ICH because the syndrome presents with severe headache, nausea, and vomiting but usually lacks hemiplegia, whose symptoms resemble that of CHS without ICH. However, SAH following CAS requires prompt differential diagnosis owing to the fatal outcome.
Seven reported cases of SAH following CAS, and the present case, are shown in Table 1 . [5] [6] [7] [8] [9] [10] The ages ranged from 43 to 78 years (average 61.1 years), consisting of three women (37.5%) and five men (62.5%). All cases had high-grade stenosis and most internal carotid arteries were symptomatic stenosis (87.5%). All cases were diagnosed by NCCT within at least 24 hours after CAS procedures (mean 6.9 hours). Poor outcome of death is reported in five of eight cases (62.5%). Symptoms are headache, nausea, vomiting, and disturbance of consciousness. These non-specific symptoms made differential diagnosis so difficult that two cases took time until NCCT was performed. 9, 10 High-grade symptomatic stenosis with the aforementioned symptoms may require immediate NCCT following a CAS procedure. The contrast medium on the right sylvian fissure proves that the SAH onset occurred during the procedure. The second NCCT showing increased SAH proves that the bleeding persisted for a while after the first NCCT. The mean onset time of SAHs following CAS ranges from 6.1 hours to 1.7 days and intraoperative bleeding is not rare shown in the presented case. 4, 5 While SAH accounts for a small percentage in the post-CAS course, the diagnosis tends to be late owing to nonspecific symptoms. Maintaining strict intraoperative and postoperative blood pressure control is recommended for CAS patients.
The mechanism of SAH following CAS is not detected, unlike aneurysmal SAH. Although the arterial wall located in the subarachnoid space distal to the circle of Willis is considered to be a rupture point, 4 an autopsy report failed to detect the cause of SAH. 6 Likewise, the leakage of contrast medium occupying the right sylvian fissure in the present case suggests the rupture of the arterial wall distal to the circle of Willis, but the rupture point was not detected. Reportedly, prolonged hypoperfusion dilates small arterioles to supply adequate blood flow and impairs autoregulation, causing a lack of reconstruction ability. 6 In this case, the elevated perfusion following CAS might disrupt the arterioles in the sylvian fissure to cause SAH. This idiopathic mechanism requires differential diagnosis in patients with SAH following CAS from aneurysms, dissections, arteriovenous malformations, and dural-arteriovenous fistulas. Careful examination of preoperational images and intraoperational angiography to exclude a mechanical cause of SAH is required when SAH was shown to follow CAS.
Neurological monitoring and strict blood pressure control are important in the prevention and treatment of ICH following CAS associated with CHS. Although strict control of postoperative blood pressure is reported to prevent ICH after CEA, the role in CAS is controversial. 4 The very prompt onset of ICH after CAS, which sometimes occurs during the procedure, may account for this phenomenon. Strict blood pressure control may need to start intraoperatively. Neurological monitoring helps to diagnose CHS during the procedure. Transcranial Doppler can increase peak velocity of the middle cerebral artery, which suggests CHS. 8 The risk factors for CHS include age, long-standing hypertension, high-grade stenosis, poor collateral blood flow, contralateral carotid artery occlusion, pretreatment cerebral vasoreactivity, and pretreatment asymmetry of resting cerebral blood flow. 14 General anesthesia and staged angioplasty are considered for the patients who have several risk factors of CHS. 5, 11 Conclusion SAH following CAS associated with CHP is very rare. However, the syndrome has a fatal outcome and it is difficult to make a differential diagnosis without imaging studies from CHS without ICH. Strict control of intraoperative and postoperative blood pressure may improve the outcome of SAH following CAS, though the role in preventing ICH after CAS is unclear.
